Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kudiezi and Xueshuantong in Acute Cerebral Infarction
NCT02544087Unknown
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Kudiezi and panax notoginseng extract in ischemic stroke (4 arms). Primary endpoint: modified Rankin Scale at 180 days. Status: unknown.
02
Drugs
Kudiezipanax notoginseng extract
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02544087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544087.